annual CFI:
-$228.65M-$134.40M(-142.60%)Summary
- As of today (September 19, 2025), VRDN annual cash flow from investing activities is -$228.65 million, with the most recent change of -$134.40 million (-142.60%) on December 31, 2024.
- During the last 3 years, VRDN annual CFI has fallen by -$154.36 million (-207.77%).
- VRDN annual CFI is now -910.07% below its all-time high of $28.23 million, reached on December 31, 2019.
Performance
VRDN Cash from investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CFI:
$75.72M-$24.34M(-24.33%)Summary
- As of today (September 19, 2025), VRDN quarterly cash flow from investing activities is $75.72 million, with the most recent change of -$24.34 million (-24.33%) on June 30, 2025.
- Over the past year, VRDN quarterly CFI has increased by +$13.74 million (+22.17%).
- VRDN quarterly CFI is now -24.33% below its all-time high of $100.06 million, reached on March 31, 2025.
Performance
VRDN quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CFI:
$28.20M+$13.74M(+95.06%)Summary
- As of today (September 19, 2025), VRDN TTM cash flow from investing activities is $28.20 million, with the most recent change of +$13.74 million (+95.06%) on June 30, 2025.
- Over the past year, VRDN TTM CFI has increased by +$230.94 million (+113.91%).
- VRDN TTM CFI is now -62.63% below its all-time high of $75.46 million, reached on September 30, 2023.
Performance
VRDN TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash from investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
VRDN Cash from investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -142.6% | +22.2% | +113.9% |
| 3 y3 years | -207.8% | +442.3% | +155.2% |
| 5 y5 years | -910.1% | +100.0% | +40.8% |
VRDN Cash from investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -207.8% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
| 5 y | 5-year | -910.1% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
| alltime | all time | -910.1% | at low | -24.3% | +144.6% | -62.6% | +108.4% |
VRDN Cash from investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $75.72M(-24.3%) | $28.20M(+95.1%) |
| Mar 2025 | - | $100.06M(-259.0%) | $14.46M(-106.3%) |
| Dec 2024 | -$228.65M(+142.6%) | -$62.91M(-25.7%) | -$228.65M(-31.8%) |
| Sep 2024 | - | -$84.67M(-236.6%) | -$335.45M(+65.5%) |
| Jun 2024 | - | $61.98M(-143.3%) | -$202.74M(-9.5%) |
| Mar 2024 | - | -$143.04M(-15.7%) | -$224.00M(+137.7%) |
| Dec 2023 | -$94.25M(-18.1%) | -$169.71M(-453.3%) | -$94.25M(-224.9%) |
| Sep 2023 | - | $48.04M(+18.0%) | $75.46M(+175.2%) |
| Jun 2023 | - | $40.71M(-406.2%) | $27.42M(+4004.5%) |
| Mar 2023 | - | -$13.29M(-195.2%) | $668.00K(-101.3%) |
| Dec 2022 | -$115.13M(+55.0%) | - | - |
| Jun 2022 | - | $13.96M(+57.5%) | -$51.13M(-33.0%) |
| Mar 2022 | - | $8.86M(-111.0%) | -$76.30M(+2.7%) |
| Dec 2021 | -$74.29M(+47.2%) | -$80.21M(-1383.2%) | -$74.29M(+59.7%) |
| Sep 2021 | - | $6.25M(-155.8%) | -$46.51M(-11.9%) |
| Jun 2021 | - | -$11.21M(-203.1%) | -$52.81M(+26.9%) |
| Mar 2021 | - | $10.87M(-120.7%) | -$41.61M(-17.6%) |
| Dec 2020 | -$50.48M(-278.8%) | -$52.43M(>+9900.0%) | -$50.48M(-664.2%) |
| Sep 2020 | - | -$53.00K(<-9900.0%) | $8.95M(-55.3%) |
| Jun 2020 | - | $0.00(-100.0%) | $20.02M(-39.4%) |
| Mar 2020 | - | $2.00M(-71.4%) | $33.05M(+17.1%) |
| Dec 2019 | $28.23M | $7.00M(-36.5%) | $28.23M(-6.9%) |
| Sep 2019 | - | $11.02M(-15.4%) | $30.32M(+128.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2019 | - | $13.03M(-561.9%) | $13.28M(-140.7%) |
| Mar 2019 | - | -$2.82M(-131.0%) | -$32.63M(+9.1%) |
| Dec 2018 | -$29.91M(-2992.4%) | $9.09M(-251.2%) | -$29.91M(-23.4%) |
| Sep 2018 | - | -$6.01M(-81.7%) | -$39.03M(+18.0%) |
| Jun 2018 | - | -$32.89M(>+9900.0%) | -$33.08M(>+9900.0%) |
| Mar 2018 | - | -$95.00K(+179.4%) | -$297.00K(-128.7%) |
| Dec 2017 | $1.03M(<-9900.0%) | -$34.00K(-46.0%) | $1.03M(-50.0%) |
| Sep 2017 | - | -$63.00K(-40.0%) | $2.07M(+133.9%) |
| Jun 2017 | - | -$105.00K(-108.5%) | $884.00K(-10.6%) |
| Mar 2017 | - | $1.24M(+23.6%) | $989.00K(-495.6%) |
| Dec 2016 | -$3000.00(-96.8%) | $1.00M(-180.2%) | -$250.00K(-79.6%) |
| Sep 2016 | - | -$1.25M(<-9900.0%) | -$1.22M(-6215.0%) |
| Jun 2016 | - | $0.00(-100.0%) | $20.00K(-600.0%) |
| Mar 2016 | - | -$3000.00(-111.1%) | -$4000.00(-91.1%) |
| Dec 2015 | -$95.00K(-65.3%) | $27.00K(-775.0%) | -$45.00K(-86.5%) |
| Sep 2015 | - | -$4000.00(-83.3%) | -$333.40K(-1.3%) |
| Jun 2015 | - | -$24.00K(-45.5%) | -$337.70K(+7.7%) |
| Mar 2015 | - | -$44.00K(-83.2%) | -$313.70K(+16.3%) |
| Dec 2014 | -$274.00K(-4666.7%) | -$261.40K(+3049.4%) | -$269.70K(+2374.3%) |
| Sep 2014 | - | -$8300.00(+219.2%) | -$10.90K(+319.2%) |
| Dec 2013 | $6000.00(-105.0%) | -$2600.00(-106.9%) | -$2600.00(-106.9%) |
| Dec 2012 | -$119.40K | - | - |
| Dec 2012 | - | $37.50K | $37.50K |
FAQ
- What is Viridian Therapeutics, Inc. annual cash flow from investing activities?
- What is the all time high annual CFI for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. annual CFI year-on-year change?
- What is Viridian Therapeutics, Inc. quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. quarterly CFI year-on-year change?
- What is Viridian Therapeutics, Inc. TTM cash flow from investing activities?
- What is the all time high TTM CFI for Viridian Therapeutics, Inc.?
- What is Viridian Therapeutics, Inc. TTM CFI year-on-year change?
What is Viridian Therapeutics, Inc. annual cash flow from investing activities?
The current annual CFI of VRDN is -$228.65M
What is the all time high annual CFI for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high annual cash flow from investing activities is $28.23M
What is Viridian Therapeutics, Inc. annual CFI year-on-year change?
Over the past year, VRDN annual cash flow from investing activities has changed by -$134.40M (-142.60%)
What is Viridian Therapeutics, Inc. quarterly cash flow from investing activities?
The current quarterly CFI of VRDN is $75.72M
What is the all time high quarterly CFI for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high quarterly cash flow from investing activities is $100.06M
What is Viridian Therapeutics, Inc. quarterly CFI year-on-year change?
Over the past year, VRDN quarterly cash flow from investing activities has changed by +$13.74M (+22.17%)
What is Viridian Therapeutics, Inc. TTM cash flow from investing activities?
The current TTM CFI of VRDN is $28.20M
What is the all time high TTM CFI for Viridian Therapeutics, Inc.?
Viridian Therapeutics, Inc. all-time high TTM cash flow from investing activities is $75.46M
What is Viridian Therapeutics, Inc. TTM CFI year-on-year change?
Over the past year, VRDN TTM cash flow from investing activities has changed by +$230.94M (+113.91%)